| |
| |
> |
"Drugs
on Target" - the best of
three worlds
The Center for Drug
Research, Development and Safety
(ZAFES) was founded at the Johann
Wolfgang Goethe University in
Frankfurt in 2002 as a “center
of excellence” and core
of a think-tank to combine the
best knowledge of the three
worlds “university”,
“pharmaceutical industry”
and “biotechnology”
in order to find innovative
drugs in a more rapid process.
Scientist of the university’s
fields “chemical and biological
sciences” and “human
medicine” working closely
in this dynamic network are
focussing on the three research
areas “pain”, “inflammation”
and “cancer”. Competencies
from pharma and active substance
research and the Clinic of the
University are joined with pharmaceutical
industry and biotechnology partners
and thus are able to work efficiently
on basic research, development
and trial processes within the
“center of excellence”
ZAFES.
Basis for ZAFES is the combination
of university resources and
experts as well as a networking
infrastructure between work
groups and institutes. This
process enables research projects
that can not be handled efficiently
through one single institution.
Partnerships with industry and
biotechnology companies can
be realized more efficiently
and successful. ZAFES is open
for all researching pharmaceutical
companies.
ZAFES is a logical development
of activities and co-operations
that have been ongoing within
the Frankfurt University as
well as with industrial partners.
It stands for one of three pillars
of the think-tank within the
Rhein-Main area regarding innovative
drugs. The two remaining pillars
are the “
Innovationcenter for Biotechnology
Frankfurt ” (FIZ)
and the “Rhein-Main
Center for Clinical studies”,
which is integrated in ZAFES.
|
> |
Goal
The innovative concept of ZAFES
will enforce Frankfurt’s
scientific site and will create
one of the best European pharmaceutical
research networks in the Rhein-Main
area on a mid- and long-term
basis. Even in its early stages,
ZAFES has no need to fear competing
research networks due to its
singular position in Germany.
For one thing, nearly the entire
value chain for the development
of a drug is represented, beginning
with the basic research via
pharmaceutical technology to
clinical development. Secondly,
leading researching pharma and
biotechnology companies have
settled in the region.
|
> |
Organisation
ZAFES is headed
by the four ZAFES
Board Members
as well as the Managing
Director.
Beginning 2005, 29 university
professors represented the
members of
ZAFES along with approx. 400
scientists on the
various projects. 28
project coordinators are
in charge of the rapid development
of
projects connecting the various
fields. ZAFES offers organisational
support regarding project management
as well as external networks
and funding.
|
|
|
|
|
